TLPH
Price
$0.55
Change
+$0.03 (+5.77%)
Updated
Sep 5 closing price
Capitalization
11.27M
TXMD
Price
$1.08
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
12.5M
71 days until earnings call
Interact to see
Advertisement

TLPH vs TXMD

Header iconTLPH vs TXMD Comparison
Open Charts TLPH vs TXMDBanner chart's image
Talphera
Price$0.55
Change+$0.03 (+5.77%)
Volume$149.11K
Capitalization11.27M
TherapeuticsMD
Price$1.08
Change-$0.00 (-0.00%)
Volume$18.85K
Capitalization12.5M
TLPH vs TXMD Comparison Chart in %
Loading...
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TLPH vs. TXMD commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TLPH is a Hold and TXMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (TLPH: $0.55 vs. TXMD: $1.08)
Brand notoriety: TLPH and TXMD are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TLPH: 8% vs. TXMD: 101%
Market capitalization -- TLPH: $11.27M vs. TXMD: $12.5M
TLPH [@Pharmaceuticals: Generic] is valued at $11.27M. TXMD’s [@Pharmaceuticals: Generic] market capitalization is $12.5M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TLPH’s FA Score shows that 0 FA rating(s) are green whileTXMD’s FA Score has 0 green FA rating(s).

  • TLPH’s FA Score: 0 green, 5 red.
  • TXMD’s FA Score: 0 green, 5 red.
According to our system of comparison, both TLPH and TXMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TLPH’s TA Score shows that 5 TA indicator(s) are bullish while TXMD’s TA Score has 4 bullish TA indicator(s).

  • TLPH’s TA Score: 5 bullish, 4 bearish.
  • TXMD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TLPH is a better buy in the short-term than TXMD.

Price Growth

TLPH (@Pharmaceuticals: Generic) experienced а +1.52% price change this week, while TXMD (@Pharmaceuticals: Generic) price change was -2.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

TXMD is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TXMD($12.5M) has a higher market cap than TLPH($11.3M). TXMD YTD gains are higher at: 25.581 vs. TLPH (4.789). TXMD has higher annual earnings (EBITDA): -1.37M vs. TLPH (-11.38M). TLPH has more cash in the bank: 6.79M vs. TXMD (6.07M). TLPH has less debt than TXMD: TLPH (3.37M) vs TXMD (6.6M). TXMD has higher revenues than TLPH: TXMD (2.56M) vs TLPH (27K).
TLPHTXMDTLPH / TXMD
Capitalization11.3M12.5M90%
EBITDA-11.38M-1.37M831%
Gain YTD4.78925.58119%
P/E RatioN/AN/A-
Revenue27K2.56M1%
Total Cash6.79M6.07M112%
Total Debt3.37M6.6M51%
FUNDAMENTALS RATINGS
TLPH vs TXMD: Fundamental Ratings
TLPH
TXMD
OUTLOOK RATING
1..100
9883
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9992
PRICE GROWTH RATING
1..100
4662
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5046

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TXMD's Valuation (42) in the Pharmaceuticals Generic industry is in the same range as TLPH (52) in the Pharmaceuticals Other industry. This means that TXMD’s stock grew similarly to TLPH’s over the last 12 months.

TXMD's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as TLPH (100) in the Pharmaceuticals Other industry. This means that TXMD’s stock grew similarly to TLPH’s over the last 12 months.

TXMD's SMR Rating (92) in the Pharmaceuticals Generic industry is in the same range as TLPH (99) in the Pharmaceuticals Other industry. This means that TXMD’s stock grew similarly to TLPH’s over the last 12 months.

TLPH's Price Growth Rating (46) in the Pharmaceuticals Other industry is in the same range as TXMD (62) in the Pharmaceuticals Generic industry. This means that TLPH’s stock grew similarly to TXMD’s over the last 12 months.

TLPH's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as TXMD (100) in the Pharmaceuticals Generic industry. This means that TLPH’s stock grew similarly to TXMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TLPHTXMD
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
67%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 14 days ago
77%
Bullish Trend 13 days ago
69%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LPTX0.28N/A
+0.11%
Leap Therapeutics
LNSR12.17N/A
N/A
LENSAR
DRI210.14-0.05
-0.02%
Darden Restaurants
MNMD9.22-0.01
-0.11%
Mind Medicine (MindMed)
APAM46.30-0.69
-1.47%
Artisan Partners Asset Management

TLPH and

Correlation & Price change

A.I.dvisor tells us that TLPH and LVZPF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPH and LVZPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPH
1D Price
Change %
TLPH100%
+6.50%
LVZPF - TLPH
31%
Poorly correlated
N/A
TXMD - TLPH
25%
Poorly correlated
N/A
RDY - TLPH
22%
Poorly correlated
+1.34%
HROW - TLPH
22%
Poorly correlated
+2.18%
SIGA - TLPH
21%
Poorly correlated
-0.82%
More

TXMD and

Correlation & Price change

A.I.dvisor tells us that TXMD and ASRT have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TXMD and ASRT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TXMD
1D Price
Change %
TXMD100%
N/A
ASRT - TXMD
27%
Poorly correlated
-1.19%
TLPH - TXMD
25%
Poorly correlated
+6.50%
TLRY - TXMD
24%
Poorly correlated
+3.48%
SCYX - TXMD
22%
Poorly correlated
+2.43%
RMTI - TXMD
22%
Poorly correlated
-3.57%
More